Cathie T. Chung, M.D.
Dr. Cathie T. Chung is a hematologist and oncologist who is currently affiliated with Cedars-Sinai Marina del Rey Hospital. She received her medical degree from the George Washington University School of Medicine and her Doctor of Philosophy degree from the University of Illinois Health Sciences. Specializing in breast cancer, the physician has been practicing for over 20 years. In 2013, the oncologist was part of the team of the clinical trial known as Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer (MONALEESA-2), which was sponsored by Novartis Pharmaceuticals.
Insurance Accepted
- Aetna
- Blue Cross / Blue Shield
- CareFirst BCBS
- Cigna
- MultiPlan
Languages Spoken
- English
- Spanish
Education & Training
Medical Degree
George Washington University School of Medicine
Internship(s)
University of California, San Francisco- Internal Medicine
Residency(ies)
University of California, San Francisco- Internal Medicine
Fellowship(s)
Stanford University Medical Center- Oncology
Publications & Media
-
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
Emens, L. A., Cruz, C., Eder, J. P., Braiteh, F., Chung, C., Tolaney, S. M., Kuter, I., Nanda, R., Cassier, P. A., Delord, J. P., Gordon, M. S., ElGabry, E., Chang, C. W., Sarkar, I., Grossman, W., O'Hear, C., Fassò, M., Molinero, L., Schmid, P.
-
Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
Lee, L.A., Silverstein, M.J., Chung, C.T., Macdonald, H., Sanghavi, P., Epstein, M., Holmes, D.R., Silberman, H., Ye, W., Lagios, M.D.
-
The role of aromatase inhibitors in early breast cancer.
Chung, C.T., Carlson, R.W.
-
Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers.
Hurria, A., Wong, F.L., Villaluna, D., Bhatia, S., Chung, C.T., Mortimer, J., Hurvitz, S., Naeim, A
-
Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
Hurria, A., Wong, F.L., Pal, S., Chung, C.T., Bhatia, S., Mortimer, J., Somlo, G., Hurvitz, S., Villaluna, D., Naeim, A.
-
Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.
Carlson, R.W., Theriault, R., Schurman, C.M., Rivera, E., Chung, C.T., Phan, S., Arun, B., Dice, K., Chiv, V.Y., Green, M., Valero, V.
-
Inflammatory breast cancer: the road to progress.
Chung, C.T., Martino, S.
-
Impact of Multifocality and Lymph Node Metastasis on the Prognosis and Management of Microinvasive Breast Cancer.
Kapoor, N. S., Shamonki, J., Sim, M. S., Chung, C. T., Giuliano, A. E.
-
Barriers to treatment in patients with locally advanced breast cancer.
Bourdeanu, L., Luu, T., Baker, N., Swain-Cabriales, S., Chung, C. T., Mortimer, J., Hurria, A., Helton, S., Smith, D., Ferrell, B., Juarez, G., Somlo, G.
-
Age-Related Changes in Nanoparticle Albumin-Bound Paclitaxel Pharmacokinetics and Pharmacodynamics: Influence of Chronological Versus Functional Age.
Hurria, A., Blanchard, M. S., Synold, T. W., Mortimer, J., Chung, C. T., Luu, T., Katheria, V., Rotter, A. J., Wong, C., Choi, A., Feng, T., Ramani, R., Doan, C. M., Brown, J., Somlo, G.
-
Goals and objectives in the management of metastatic breast cancer.
Chung, C.T., Carlson, R.W.